Atlas FDA

SUPARTZ FX and VISCO-3

FDA premarket approval P980044/S047 · decided 2018-08-16

Approval details

PMA number
P980044
Supplement
S047
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
SUPARTZ FX and VISCO-3
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2018-05-18
Decision date
2018-08-16
Days to decision
90 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
Approval for a change to the shape of the finger grip component of the syringe container closure system for SUPARTZ FX and VISCO-3 and for modifications to assembly and blister packaging equipment.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15